Table 2 Association of baseline clinicopathologic characteristics and HALP
Variable | n (%) | Â | HALPa | |
|---|---|---|---|---|
| Â | Â | low (%) | high (%) | P value |
All patients | 1360 | 291 (21.40%) | 1069 (78.60%) | Â |
Gender |  |  |  | < 0.001 |
 male | 952 (70.00%) | 162 (17.02%) | 790 (82.98%) |  |
 female | 408 (30.00%) | 129 (31.62%) | 279 (68.38%) |  |
Age, years |  |  |  | < 0.001 |
  ≤ 65 | 997 (73.31%) | 186 (18.66%) | 811 (81.34%) |  |
 >65 | 363 (26.69%) | 105 (28.93%) | 258 (71.07%) |  |
Histology subtype | Â | Â | Â | 0.695 |
 ccRCC | 1228 (90.29%) | 261 (21.25%) | 967 (78.75%) |  |
 non-ccRCC | 132 (9.71%) | 30 (22.73%) | 102 (77.27%) |  |
ASA grade | Â | Â | Â | 0.361 |
 1 + 2 | 1264 (92.94%) | 268 (21.20%) | 996 (78.80%) |  |
 3 + 4 | 96 (7.06%) | 23 (23.96%) | 68 (76.04%) |  |
Fuhrman grade |  |  |  | < 0.001 |
 1 + 2 | 1112 (81.76%) | 177 (15.92%) | 935 (84.08%) |  |
 3 + 4 | 248 (18.24%) | 113 (45.56%) | 130 (54.44%) |  |
T stage |  |  |  | < 0.001 |
 1 + 2 | 1128 (82.94%) | 173 (15.34%) | 955 (84.66%) |  |
 3 + 4 | 232 (17.06%) | 118 (50.86%) | 113 (49.14%) |  |
N status |  |  |  | < 0.001 |
 negative | 1327 (97.57%) | 270 (20.35%) | 1057 (79.65%) |  |
 positive | 33 (2.43%) | 21 (63.64%) | 12 (36.36%) |  |
Metastasis |  |  |  | < 0.001 |
 negative | 1299 (95.51%) | 258 (19.86%) | 1041 (80.14%) |  |
 positive | 61 (4.49%) | 33 (54.10%) | 28 (45.90%) |  |
Sarcomatoid transformation |  |  |  | < 0.001 |
 absent | 1295 (95.22%) | 245 (18.92%) | 1050 (81.08%) |  |
 present | 65 (4.78%) | 46 (70.77%) | 19 (29.23%) |  |
Tumor necrosis |  |  |  | < 0.001 |
 absent | 940 (69.12%) | 158 (16.81%) | 782 (83.19%) |  |
 present | 420 (30.88%) | 133 (31.67%) | 286 (68.33%) |  |
Lymphovascular invasion |  |  |  | < 0.001 |
 absent | 1260 (92.65%) | 249 (19.76%) | 1011 (80.24%) |  |
 present | 100 (7.35%) | 42 (42%) | 58 (58%) |  |
NLR |  |  |  | < 0.001 |
 high | 317 (23.3%) | 166 (52.37%) | 151 (47.63%) |  |
 low | 1043 (76.7%) | 125 (11.98%) | 918 (88.02%) |  |
PLR |  |  |  | < 0.001 |
 high | 195 (14.3%) | 180 (92.31%) | 15 (7.69%) |  |
 low | 1165 (85.7%) | 111 (9.53%) | 1054 (90.47%) |  |